Drug for clinically treating pulmonary tuberculosis
A technology for clinical treatment of pulmonary tuberculosis, which is applied in the field of medicine and can solve problems such as obvious toxic and side effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment approach 1
[0008] Embodiment 1: The drug for the clinical treatment of pulmonary tuberculosis is made of 22 g of ethambutol, 18 g of starch, and 41 g of biological agent. Put the ethambutol, starch, and biological preparations in the above parts by weight in a high-speed mixing granulator, dry-mix quickly for 5 minutes, add an appropriate amount of 10% starch slurry and stir at a low speed for 3 minutes, and quickly make wet granules. The wet granules are sent to a fluidized bed of a fluidized drier and dried at 60°C for 20 minutes. After drying, the moisture content is controlled to 7%, and the dried granules are collected after cooling. Put the dry granules into a granulator, pass through a 14-mesh sieve for granulation, add magnesium stearate with 1% of the total weight of the granules, put them into a three-dimensional motion mixer and mix for 10 minutes before weighing and pressing. bottle packaging. The biological preparation is prepared by soaking 100g of Rosa obtuse leaf, 21g of...
Embodiment approach 2
[0009] Embodiment 2: The drug for the clinical treatment of pulmonary tuberculosis is made of 24 g of ethambutol, 21 g of starch, and 44 g of biological preparations, and the preparation method is the same as that of Embodiment 1.
Embodiment approach 3
[0010] Embodiment 3: The drug for the clinical treatment of pulmonary tuberculosis is made from 26 g of ethambutol, 24 g of starch, and 47 g of biological preparations, and the preparation method is the same as that of Embodiment 1.
[0011] Quality inspection of pharmaceutical tablet of the present invention
[0012] In this study, three batches of test products were prepared, and the disintegration time limit, dissolution rate and stability were investigated according to the methods of "Chinese Pharmacopoeia".
[0013] ①Disintegration time limit inspection
[0014] According to the method under the method of disintegration time limit inspection method in Appendix X A of the 2005 edition of the Chinese Pharmacopoeia, the average disintegration time limits of the three batches were (8.06±2.21) min, (8.13±2.19) min, (8.08 ±2.21)min, all within 15min, complying with the regulations.
[0015] ②Dissolution test
[0016] According to "Chinese Pharmacopoeia" 2005 edition two appe...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com